Alphabet Form 144 Reports 12,000-Share Sale, Recent 10b5-1 Sales
Rhea-AI Filing Summary
Form 144 notice relates to a proposed sale of 12,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $2,435,280 and an approximate sale date of 08/15/2025 on NASDAQ. The filing states these 12,000 shares were acquired as founders' shares on 09/07/1998 and payment was recorded on that date. The filing also discloses multiple recent 10b5-1 sales in the past three months: 15,000 shares on 07/18/2025 ($2,786,400), 18,566 shares on 07/18/2025 ($3,448,820.16), 9,000 shares on 05/22/2025 ($1,575,000), and 10,500 shares on 05/22/2025 ($1,837,500). The notice includes the standard representation that the seller does not possess undisclosed material adverse information.
Positive
- Discloses a specific proposed sale of 12,000 shares with an aggregate market value of $2,435,280, providing transparency.
- Reports multiple recent sales executed under 10b5-1 plans totaling 53,066 shares and approximately $9.647 million in gross proceeds, which clarifies recent insider liquidity activity.
- Includes the seller's formal representation that they do not possess undisclosed material adverse information, meeting Form 144 compliance requirements.
Negative
- None.
Insights
TL;DR: Routine Form 144 reporting of a proposed sale and recent 10b5-1 plan sales; appears informational and not immediately market-moving.
The filing documents a proposed sale of 12,000 common shares valued at $2,435,280 through Morgan Stanley Smith Barney with an intended sale date of 08/15/2025. It also lists four 10b5-1 sales executed in May and July 2025 totaling 53,066 shares and about $9.647 million in gross proceeds. Based solely on the disclosed numbers, this is a regulatory notice of intent to sell and prior plan-based sales; the filing does not disclose any new operational or financial information about the issuer to indicate a material change in company fundamentals.
TL;DR: Disclosure aligns with Rule 144 and 10b5-1 reporting requirements; the seller affirms no undisclosed material information.
The document provides the statutory representations required by Form 144, including the seller's certification regarding material adverse information. It records that the 12,000 shares were acquired as founders' shares on 09/07/1998 and notes multiple recent sales labeled as 10b5-1, which suggests preplanned transactions. The filing contains no governance actions, director changes, or other corporate events. Its primary function is compliance and transparency about intended and recent sales.